Amazing how Alto raised $7m in a day in this market. This IPO hasn't been promoted and will will surprise many!
Anti aging drug development is a booming business in the US.
Regenerative medicine seeks to address this challenge and extend the duration of our wellness and capacity.
Dr Dixon, the founder was also the co-founder of Cynata Therapeutics (ASX:CYP) and a director of Noxopharm (ASX:NOX).
"Many scientists now believe Exosomes are the next evolution in Stem Cell technology,"
Dr. Ronald Klatz, President of the American Academy of Anti-Aging and Regenerative Medicine
Amazing how Alto raised $7m in a day in this market. This IPO...
-
- There are more pages in this discussion • 49 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
